1 0

    FDA BLA 125057, Supplement S-400, Humira, Approved on October 17, 2016

    FDA BLA 125057, Supplement S-400, Humira, Approved on October 17, 2016

    $184.95 USD
    $184.95 USD
    Sale Sold out

    Content: Approval letter and supporting records for Humira, BLA 125057, Supplement S-400, approved on October 17, 2016, partially redacted.

    Drug Name: Humira
    Active Ingredients: Adalimumab
    Strength: 40MG/0.8ML
    Dosage Form/Route: Both Syringe and Vial
    Marketing Status: Prescription
    TE Code: None
    RLD: No
    RS: NoAction Date: 12/31/2002

    Pages: 137
    Redacted Pages: 102
    Content Pages: 35
    View full details